Patriot Financial Group Insurance Agency, LLC Voyager Therapeutics, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$685 Million
Q1 2025

A detailed history of Patriot Financial Group Insurance Agency, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Patriot Financial Group Insurance Agency, LLC holds 110,098 shares of VYGR stock, worth $383,141. This represents 0.06% of its overall portfolio holdings.

Number of Shares

110,098

Previous 112,198 1.87%

Holding current value

$383,141

Previous $636,000 36.95%

% of portfolio

0.06%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	SELL	$3.38 - $6.04 $7,098 - $12,684	-2,100 Reduced 1.87%	110,098 $401,000
Q4 2024 Jan 22, 2025	SELL	$5.27 - $8.07 $130,147 - $199,296	-24,696 Reduced 18.04%	112,198 $636,000
Q3 2024 Oct 24, 2024	BUY	$5.77 - $9.27 $51,929 - $83,430	9,000 Added 7.04%	136,894 $800,000
Q2 2024 Jul 26, 2024	BUY	$7.42 - $10.54 $948,973 - $1.35 Million	127,894 New	127,894 $1.01 Million
Q2 2022 Jul 29, 2022	BUY	$4.82 - $10.09 $949 - $1,987	197 Added 3.84%	5,325 $31,000
Q1 2022 May 11, 2022	BUY	$2.75 - $9.44 $8 - $28	3 Added 0.06%	5,128 $39,000
Q4 2021 Jan 10, 2022	BUY	$2.47 - $5.55 $11,757 - $26,418	4,760 Added 1304.11%	5,125 $14,000
Q3 2021 Nov 24, 2021	SELL	$2.63 - $4.12 $957 - $1,499	-364 Reduced 49.93%	365 $1,000
Q4 2020 Jan 15, 2021	SELL	$7.15 - $12.28 $231,938 - $398,350	-32,439 Reduced 97.8%	729 $5,000
Q3 2020 Oct 21, 2020	BUY	$10.01 - $13.75 $35,555 - $48,840	3,552 Added 11.99%	33,168 $354,000
Q2 2020 Jul 10, 2020	BUY	$8.05 - $14.21 $16,019 - $28,277	1,990 Added 7.2%	29,616 $374,000
Q1 2020 Apr 15, 2020	BUY	$6.8 - $14.66 $84,524 - $182,223	12,430 Added 81.8%	27,626 $253,000
Q4 2019 Jan 22, 2020	SELL	$12.82 - $16.85 $84,663 - $111,277	-6,604 Reduced 30.29%	15,196 $212,000
Q3 2019 Oct 25, 2019	SELL	$16.31 - $28.29 $503,930 - $874,076	-30,897 Reduced 58.63%	21,800 $375,000
Q2 2019 Aug 07, 2019	SELL	$19.18 - $27.88 $155,300 - $225,744	-8,097 Reduced 13.32%	52,697 $1.45 Million
Q1 2019 Apr 29, 2019	SELL	$8.0 - $19.66 $4,208 - $10,341	-526 Reduced 0.86%	60,794 $1.16 Million
Q4 2018 Feb 04, 2019	BUY	$8.59 - $18.05 $6,305 - $13,248	734 Added 1.21%	61,320 $576,000
Q3 2018 Oct 30, 2018	SELL	$17.11 - $21.74 $62,793 - $79,785	-3,670 Reduced 5.71%	60,586 $1.15 Million
Q2 2018 Aug 14, 2018	BUY	$16.76 - $23.92 $189,505 - $270,463	11,307 Added 21.35%	64,256 $1.26 Million
Q1 2018 May 14, 2018	BUY	$16.16 - $31.31 $723,143 - $1.4 Million	44,749 Added 545.72%	52,949 $962,000
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $100,532 - $212,216	8,200	8,200 $132,000

Others Institutions Holding VYGR

# of Institutions

135

Shares Held

34.1M

Call Options Held

Put Options Held

60.4K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $134M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account

Patriot Financial Group Insurance Agency, LLC Voyager Therapeutics, Inc. Transaction History